LifeStance Health Group, Inc. (NASDAQ: LFST) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $345.3 million versus the consensus estimate of $345.05 million.

GUIDANCE:

LifeStance Health Group, Inc. sees FY2025 revenue of $1.4-1.44 billion, versus the consensus of $1.412 billion.

For earnings history and earnings-related data on LifeStance Health Group, Inc. (LFST) click here.